Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Advocates often emphasize the possibility for significant therapeutic benefits, especially in diseases where conventional treatments have proven inadequate. However, crucially important to consider the considerable financial burden associated with